Cell counting and analysis just got easier and better
Eikonix are pleased to announce that they have been appointed by Countstar to sell their automated cell counters and fluorescence cell analyser in the UK. Featuring ease of use, efficiency, accuracy and reliability, these products have been widely used in major research and medical institutions in various fields including biopharmaceuticals, beer and beverages.
Key achievements include facilities, research and development, partnerships and recruitment
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the release of their 2015 Annual Review. The second review covers the 12 months from April 2014 to 2015, during which the Cell Therapy Catapult...
The World Market for Liquid Chromatography in Healthcare, provides useful business planning information and competitive analysis for this particular industry, including Market Size, Forecast, Research and Clinical Markets, Market Share, Analyst Commentary and Corporate Profiles. This is slow-evolving industry but recently, new technologies and applications are providing change in the market. The report covers these trends in detail...
MR Solutions and Summit Pharmaceuticals have reached an agreement where Summit Pharmaceuticals will be the sole supplier for MR Solutions’ preclinical, multi-modality cryogen free MRI imaging systems to the Japanese market.
Summit Pharmaceuticals, part of the Sumitomo Corporation, is a leading Japanese provider of drug discovery instruments and through this partnership, both companies will be able to offer a complete imaging portfolio of high field preclinical multi-modality MRI solutions including PET/MR and SPECT/MR, plus CT, optical systems, and bioresource materials. Based in Surrey, UK, MR Solutions pioneered the development of the world’s...
Frost & Sullivan Recognizes Potential for its ‘Groundbreaking’ Functionality
Medtech innovator Medimetrics has won the 2015 Frost & Sullivan Award for ‘Product Innovation in Personalized Drug Delivery’ for its IntelliCap micro-electronics, oral drug delivery system. The award is open to companies trading in North America.IntelliCap enables the pre cise delivery of drugs in the gastro-intestinal tract and the measurement and reporting of conditions in the body. The official Frost & Sullivan report...
As part of the annual awards ceremony for the Lifetime Business Achievement Medal of Honor event, the Secretary of State for Trade and Industry Nils Shmid presented Gerhard Juchheim with the Lifetime Business Achievement Medal of Honor for 2015 from the state of Baden-Württemberg.
Since 1978 this award has been bestowed on leaders and companies for their outstanding professional and entrepreneurial achievements. Gerhard Juchheim was honored for his lifetime business contribution in Baden-Württemberg by Mr. Schmid in the famous marble ballroom of the Neuen Schloss (New Castle) in Stuttgart. It was an honor not only for Gerhard Juchheim but also for the long-standing historical tradition of this family company...
Re-Pharm, an early-stage drug discovery and development company based on the principles of compound re-profiling, is pleased to announce that they have been awarded a GB patent on the re-purposed compound RP0217 for the treatment of inflammatory disorders.
This patent protects the topical use of RP0217 for the treatment or prevention of respiratory and gastrointestinal inflammatory disorders, including rhinitis, asthma, chronic obstructive pulmonary disease, ulcerative colitis, and Crohn’s disease. “Patients with chronic inflammation typically rely on steroids to control their disorders,” explains Dr Robert Scoffin, CEO of Re-Pharm. “We are delighted to have identified this non-steroidal alternative...
Gel Company celebrates 20 years of serving the life science market. Founded in 1995, Gel Company, based in San Francisco, develops manufactures, and supplies low cost products to the life science research community.
The company has set its goal to provide innovative, high quality products with an efficient, friendly service. The aim of Gel Company is to offer all its products at competitive prices. The focus is to develop, manufacture and supply innovative tools for proteomics, genomics, cell biology, liquid handling and microarray applications to scientists around the world.
Dolomite, part of the Blacktrace group of companies, is celebrating a decade of excellence in the design and manufacture of novel, high quality microfluidic products, including individual components such as pumps, chips, connectors, temperature controllers and sensors, software solutions and complete microfluidic systems.
The company, based in Royston, UK, was the world’s first microfluidic application centre, and has gone from strength to strength since its formation in 2005, opening offices in the USA, Japan, India and Brazil, and establishing a global distributor network. Today, it serves many thousands of customers in over 50 countries around the world, working in fields as diverse as academia, biotechnology, drug discovery, food and cosmetics...
LUSH Cosmetics Awards Group £25,000 for Its Educational and Training Work
The PETA International Science Consortium Ltd. will receive the prestigious LUSH Prize Training Award in London today. The award recognises the Science Consortium's multifaceted approach to providing educational outreach to companies and regulators through the organisation of webinars, initiating face-to-face training sessions, and developing educational resources to promote the acceptance and uptake of non-animal methods...
UK-based drug discovery services provider Peakdale Molecular (part of the Concept Life Sciences Group) has strengthened its sales and marketing team through the addition of a Head of Sales and Marketing.
Gordon Woodrow, BSc in Applied Microbiology, has been appointed Head of Sales and Marketing and joins Peakdale with over 25 years of commercial experience having held a number of senior positions in companies offering scientific services to the pharmaceutical and biotech industries. Prior to joining Peakdale Gordon was responsible for business development and strategic alliances at Proteros Biostructures. Whilst there Gordon played...
Trajan Scientific and Medical (Trajan) has announced the opening of a new Business Unit - Instruments, Sensors and Devices, to be located at the University of Adelaide’s Institute for Photonics and Advanced Sensing (IPAS).
Along with the new capabilities existing on that site such as glass modification and extrusion, the new Business Unit will have global responsibilities for new devices such as the recently revealed hemaPEN™ for dried blood spot sampling. This announcement comes just two months after Trajan’s landmark strategic collaboration with the University of Adelaide, supported by the South Australian Government, was revealed...
Agreement initially focuses on generation of gene edited induced pluripotent stem cells (iPSCs) for use in neuronal and cardiovascular disease research and brings together Horizon’s precision genome editing capability and Axol’s expertise in iPSC differentiation
Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, and Axol Bioscience Ltd (Axol), a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems, announce they have formed a strategic partnership...
To cope with an ever increasing demand for 24-hour turnaround of sample data, Warwick Analytical Service has invested in an additional state-of-the-art ICP spectrophotometer for its Coventry, UK facility.
Operating in an ISO 17025 and GMP compliant environment following strict operating procedures ensures Warwick Analytical Service (WAS) delivers top quality ICP data consistently. Equipped with several modern high resolution ICP-OES instruments and microwave digestion equipment - Warwick Analytical Service is able to offer its ICP analytical sample services on a wide range of sample types. Tracie Hart, Laboratory Manager at...
Bulk production facility enables company to support large diagnostics customers
Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the installation of bulk production capability for its colloidal gold nanoparticle products. The move enables the company to support any scale of operation, including the largest players in the diagnostics field. Innova’s ultra-high quality colloidal gold nanoparticles have a consistent uniform shape and size, ensuring reliability and...
The work of scientists and campaigners from around the world to end animal testing is being celebrated in a special issue of FRAME’s peer-reviewed journal ATLA (Alternatives to Laboratory Animals) Journal.
Produced each year in collaboration with the Lush Prize, the largest annual prize fund rewarding initiatives to end animal testing for toxicology research, the special issue of ATLA is a reflective look at the work of last year’s Lush Prize winners. Copies will be distributed at the awards dinner later this week. Included in the journal, are the winners of the 2014 Lush Prize for Science, Professor Grafström, and Dr Kohonen from Sweden’s Karolinska...
LGC, the international life sciences and measurement company, today announces that it has acquired Maine Standards Company, the leading provider of calibration verification materials for clinical laboratories in the US.
The acquisition bolsters LGC’s growing portfolio of reference materials and proficiency testing (PT) schemes for the clinical market. Euan O’Sullivan, Managing Director of LGC’s Standards Division, said, “We are delighted to welcome Maine Standards Company to LGC. Our two organisations represent a highly complementary commercial and cultural fit, with a common commitment to developing products of the very highest quality for the benefit of...
The inaugural Diabetes Professional Care (DPC) 2015 conference and exhibition was a major success.
Clinical scientists right through to pharmacists flocked to the Barbican Exhibition Centre to see how the new event – the UK’s only free-to-attend CPD accredited – would shape up. The overwhelming consensus was that it worked brilliantly and has plugged a major hole in the UK diabetes market. Punya Liyanage, Health Economy Liaison Manager – Diabetes – Janssen, visiting the show, enthused: “Fantastic to have a free-to-attend...
The European Commission has signed the grant agreement for the latest phase of the GÉANT project, GN4-1, which runs to April 2016 with a funding level of €25m.
"I am delighted to announce the signature of the new grant agreement between GÉANT and the EC. With this signature, we will reinforce even further our pan-European network for scientific excellence and European research and innovation. By assuring world-leading connectivity between Europe and the rest of the world in support of global research collaborations, GÉANT continues to help researchers and the wider community to...
The funds will be used to fuel international growth and to enter into the in-vitro diagnostics market.
Ovizio Imaging Systems, an innovative Belgian company developing cell counting solutions based on quantitative microscopy for life sciences applications, today announces it has secured a funding round of €8m ($9.1m) co-led by New Science Ventures, a US-based venture capital firm, and a private investor. This funding round...
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre. John Brown marked the beginning of construction at an event on the site. Marking the importance of the manufacturing centre to the international cell...
Beckman Coulter Life Sciences and IncellDx, Inc. announced today they have signed a distribution agreement which focuses exclusively on clinical researchers in China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer.
The commercial partnership brings the power of multi-parameter flow cytometry to molecular testing, improving workflow while delivering sensitive and highly reliable cell identification. IncellDx’s next generation (3Dx) investigational molecular assay used to quantify HPV E6, E7 mRNA in single cells has been specially optimized to run on Beckman Coulter’s innovative CytoFLEX flow cytometry system.* The high throughput system instrument...